Treatment of refractory ascites with an automated low flow ascites pump in patients awaiting liver transplantation

[1]  P. Deltenre,et al.  Systematic review with meta‐analysis: automated low‐flow ascites pump therapy for refractory ascites , 2019, Alimentary pharmacology & therapeutics.

[2]  C. Sinning,et al.  Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival , 2019, JHEP reports.

[3]  S. Kwan,et al.  Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunt versus Large-Volume Paracentesis in Refractory Ascites: Results of a Markov Model Incorporating Individual Patient-Level Meta-Analysis and Nationally Representative Cost Data. , 2018, Journal of vascular and interventional radiology : JVIR.

[4]  J. Trebicka,et al.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. , 2018, Journal of hepatology.

[5]  R. Jalan,et al.  Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study , 2018, Quality of Life Research.

[6]  R. Jalan,et al.  Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study. , 2017, Journal of hepatology.

[7]  F. Lammert,et al.  Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis , 2017, Alimentary pharmacology & therapeutics.

[8]  K. Watt,et al.  Review article: maximising quality of life while aspiring for quantity of life in end‐stage liver disease , 2017, Alimentary pharmacology & therapeutics.

[9]  D. Thabut,et al.  Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites. , 2017, Gastroenterology.

[10]  R. Moreau,et al.  Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. , 2015, Journal of hepatology.

[11]  J. Jang,et al.  Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score. , 2015, World journal of gastroenterology.

[12]  D. Seehofer,et al.  Predictors of quality of life in patients evaluated for liver transplantation , 2014, Clinical Transplantation.

[13]  J. Newton,et al.  Health related quality of life in people with advanced chronic liver disease. , 2014, Journal of hepatology.

[14]  Baljendra Kapoor,et al.  Transjugular Intrahepatic Portosystemic Shunt: Indications, Contraindications, and Patient Work-Up , 2014, Seminars in Interventional Radiology.

[15]  Emmanuel A Tsochatzis,et al.  Liver cirrhosis , 2014, The Lancet.

[16]  G. Han,et al.  TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. , 2014, World journal of gastroenterology.

[17]  Pedro Zapater,et al.  Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. , 2013, Journal of hepatology.

[18]  M. Poca,et al.  Development of Ascites in Compensated Cirrhosis With Severe Portal Hypertension Treated With β-Blockers , 2012, The American Journal of Gastroenterology.

[19]  H. Rousseau,et al.  Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. , 2011, Journal of hepatology.

[20]  P. Ginès,et al.  Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. , 2010, Journal of hepatology.

[21]  A. de Gottardi,et al.  Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  F. Wong,et al.  Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. , 2007, Gastroenterology.

[23]  M. Bilodeau,et al.  Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease , 2005, Alimentary pharmacology & therapeutics.

[24]  V. Arroyo,et al.  Management of cirrhosis and ascites. , 2004, The New England journal of medicine.

[25]  R. Moreau,et al.  The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club , 2003, Hepatology.

[26]  M. Reiser,et al.  A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. , 2000, The New England journal of medicine.